ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions. ANG Lifesciences India Limited was incorporated in 2006 and is based in Amritsar, India.
| Current Price | ₹28.84 |
|---|---|
| Market Cap | ₹38 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | -3 |
| Return on Equity | -17.70% |
| 52-Week Range | ₹17.63 – ₹39.70 |
| Beta (1Y) | 0.68 |
| Dividend Yield | 0.00% |
1. Pharmaceuticals-96.8% 2. Printing and Packagings-7.3%
Ang Lifesciences India Ltd is trading at ₹28.84, with a market capitalisation of ₹38 Cr.
Ang Lifesciences India Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Ang Lifesciences India Ltd has a P/E of -3 and a return on equity of -17.70%.